NCT06673680 Role Of Colposcopy In Evaluation Of Suspicious Cervix
| NCT ID | NCT06673680 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Cancer Cervix |
| Study Type | OBSERVATIONAL |
| Enrollment | 53 participants |
| Start Date | 2024-10-01 |
| Primary Completion | 2025-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 53 participants in total. It began in 2024-10-01 with a primary completion date of 2025-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
do colposcopy and cervical punch biopsy then compare between findings
Eligibility Criteria
Inclusion Criteria: * Age from 30 to 64 years old. * Women with symptoms such as white discharge, post-coital bleeding, and intermenstrual bleeding. * Women with the clinically unhealthy cervix (erosion, bleeding on touch, simple leukoplakia, keratinization) * Women with Pap smear showing dysplasia Exclusion Criteria: * Pregnant women * Women having active vaginal bleeding. * Any past treatment for cervical lesions. * Women having frank growth of cervix. * Women who underwent a hysterectomy.
Contact & Investigator
Hazem A prof, MD
STUDY DIRECTOR
Sohag university hospitals
Frequently Asked Questions
Who can join the NCT06673680 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 60 Years, studying Cancer Cervix. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06673680 currently recruiting?
Yes, NCT06673680 is actively recruiting participants. Contact the research team at kamalo.omar@gmail.com for enrollment information.
Where is the NCT06673680 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT06673680 clinical trial?
NCT06673680 is sponsored by Sohag University. The principal investigator is Hazem A prof, MD at Sohag university hospitals. The trial plans to enroll 53 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.